Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Health Catalyst Inc

HCAT
Current price
8.63 USD +0.03 USD (+0.35%)
Last closed 8.6 USD
ISIN US42225T1079
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 523 671 936 USD
Yield for 12 month +14.15 %
1Y
3Y
5Y
10Y
15Y
HCAT
21.11.2021 - 28.11.2021

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. Address: 10897 South River Front Parkway, South Jordan, UT, United States, 84095

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11 USD

P/E ratio

Dividend Yield

Current Year

+295 938 000 USD

Last Year

+276 236 000 USD

Current Quarter

+75 902 000 USD

Last Quarter

+74 723 000 USD

Current Year

+92 602 000 USD

Last Year

+133 187 000 USD

Current Quarter

+25 406 000 USD

Last Quarter

+26 097 000 USD

Key Figures HCAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -41 704 000 USD
Operating Margin TTM -15.94 %
PE Ratio
Return On Assets TTM -6.58 %
PEG Ratio
Return On Equity TTM -23.15 %
Wall Street Target Price 11 USD
Revenue TTM 299 481 984 USD
Book Value 5.94 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.7 %
Dividend Yield
Gross Profit TTM 135 561 000 USD
Earnings per share -1.49 USD
Diluted Eps TTM -1.49 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -28.87 %

Dividend Analytics HCAT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HCAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation HCAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 22.4719
Enterprise Value Revenue 1.5496
Price Sales TTM 1.7486
Enterprise Value EBITDA -4.9553
Price Book MRQ 1.4669

Financials HCAT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HCAT

For 52 weeks

5.42 USD 11.41 USD
50 Day MA 7.7 USD
Shares Short Prior Month 2 344 086
200 Day MA 7.59 USD
Short Ratio 4.89
Shares Short 2 651 596
Short Percent 4.47 %